Amlodipine/Valsartan Ingen Pharma

Medicinal product

(Invented) name

Amlodipine/Valsartan Ingen Pharma

Active substance (s)

Amlodipinas/Valsartanas

Strength

5 mg/160 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C09DB01, Valsartan and amlodipine

Marketing authorisation holder

SIA Ingen Pharma, Latvija

Date of authorisation

2016-06-17

Date of renewal

2021-10-18

Documents

3927 Pakuotės lapelis 2025 05 26.docx

3927 Amlodipine_Valsartan Ingen Pharma PCS PL 2025 05 26.docx

Amlodipine_Valsartan Ingen Pharma_AR.pdf

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Amlodipinas	5 mg
Valsartanas	160 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
62559	76970	1076970	lizdinė plokštelė	N28		Receptinis	LT/1/16/3927/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-10-18	Perregistruotas
2016-06-17	Registruotas